Nautilus Biotechnology, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Nautilus Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $142.00K, a 63.22% increase year-over-year.
- Nautilus Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $69.00K, a 70.64% decline year-over-year.
- Nautilus Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $0.00.
- Nautilus Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $87.00K, a 69.90% decline year-over-year.
- Nautilus Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $156.00K, a 70.23% decline from fiscal 2024.
- Nautilus Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $524.00K, a 98.48% increase from fiscal 2023.
- Nautilus Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $264.00K, a 13.79% increase from fiscal 2022.
- Nautilus Biotechnology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $232.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $142.00K 10-Q · filed 2026-07-28 | |
| 2025-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $156.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | |
| 2025-06-30 | $87.00K 10-Q · filed 2026-07-28 | |
| 2024-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $524.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | |
| 2024-06-30 | $289.00K 10-Q · filed 2025-07-31 | |
| 2023-12-31 | $172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $264.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | |
| 2023-06-30 | $92.00K 10-Q · filed 2024-07-30 | |
| 2022-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $232.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | |
| 2022-06-30 | $153.00K 10-Q · filed 2023-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |